Serum chemerin in patients with rheumatoid arthritis: can it unravel the Chimera of concomitant type 2 diabetes?
Guardado en:
Autor principal: | Dimitrios Patoulias |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2334f68ca9d2473a8e4486a937dcf0d7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Functional disability is related to serum chemerin levels in rheumatoid arthritis
por: Maria Luisa Vazquez-Villegas, et al.
Publicado: (2021) -
Serum chemerin and visfatin levels and their ratio as possible diagnostic parameters of rheumatoid arthritis
por: Dunia Ali, et al.
Publicado: (2020) -
Serum chemerin levels: A potential biomarker of joint inflammation in women with rheumatoid arthritis.
por: Fabiola Gonzalez-Ponce, et al.
Publicado: (2021) -
The potential value of serum chemerin in patients with breast cancer
por: Yanfang Song, et al.
Publicado: (2021) -
Apelin and chemerin as promising adipokines in children with type 1 diabetes mellitus
por: Elsehmawy AAEW, et al.
Publicado: (2019)